SRINIVAS KOLIPAKA: Open Payments
NPI 1831381433 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 24 payments from 6 companies in 2025. Trend: 2023 $62 · 2024 $59 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $175 |
| ABBVIE INC. | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: UZEDY, VRAYLAR, AUSTEDO XR, COBENFY, REJOYN, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across GA — which companies pay providers there.
